Rating Quick Look | Reddit, Palantir Target Price Raised! ARM, NetEase, Disney Face Price Cuts

LB Select
2024.05.09 09:13
portai
I'm PortAI, I can summarize articles.

CICC has cut NetEase's US stock target price by 4% to $133, expecting NetEase's first-quarter revenue to increase by 6% year-on-year to 26.4 billion yuan, while the market forecast is 26.8 billion yuan; the mobile game segment is expected to increase by 11% year-on-year to 15 billion yuan, while the market forecast is 15.5 billion yuan; non-GAAP net profit is expected to increase by 9% to 8.2 billion yuan

Bank of America: Maintains "Buy" rating on Apple, with a target price of $230

The report pointed out that Apple held the Let Loose new product launch event on May 7, introducing new versions of iPad Air, iPad Pro, Pencil Pro, and Magic Keyboard.

The new iPad's hardware can support artificial intelligence functions and applications, which is impressive. The bank also prefers the company to continue innovating on its own chips, such as introducing the new M4 chip in the iPad Pro; the advanced neural network engine in the M4 chip will enable AI functions, such as isolating subjects from backgrounds in 4K videos using Apple's Final Cut Pro, detecting documents, rearranging images with AI, and removing shadows; new features in iPadOS allow for visual search, real-time text, and subject extraction operations.

The bank mentioned that Apple's management expected double-digit growth in iPad revenue for the third quarter during the earnings conference call last week, compared to a 17% year-on-year decline in the second quarter, partly driven by sales of the new iPad.

Citi: Raises Autohome ADR's target price from $30 to $31, maintains "Buy" rating

The report states that Autohome's first-quarter profit exceeded expectations, driven by expected leads generation services and cost control. The bank also expects the company's leads services to grow moderately after contract renewals in the first quarter of this year, indicating that future growth will mainly come from data products provided to agents.

The bank adjusted its earnings forecast for the company from this year to 2026 by 1% to 2%, reflecting better-than-expected leads services and profit margins. Based on a 6.3% dividend yield and a modest valuation, the company's net cash level accounts for 96% of its current market value.

Citi: Raises Reddit's target price from $53 to $65, maintains "Buy" rating

Citi: Raises Palantir's target price from $23 to $25, maintains "Neutral" rating

Evercore: Lowers Arm's target price from $156 to $145

Wedbush: Lowers Rivian's target price from $20 to $15, reiterates "Outperform" rating

DA Davidson: Raises Lyft's target price from $15 to $18, maintains "Neutral" rating

Moffett Nathanson: Lowers Disney's target price from $135 to $130, maintains "Buy" rating

The bank stated that Disney's unique content advantage compared to other streaming platforms provides it with international growth opportunities.

CICC: Maintains "Outperform" rating on NetEase, cuts US stock target price by 4% to $133

The bank expects NetEase's first-quarter revenue to grow by 6% year-on-year to 26.4 billion yuan, while the market forecast is 26.8 billion yuan. Specifically, the bank expects mobile game revenue to increase by 11% year-on-year to 15 billion yuan, while the market forecast is 15.5 billion yuan; non-GAAP net profit is expected to rise by 9% to 8.2 billion yuan The bank stated that considering the mobile game "Yan Yun Sixteen Sounds" has not been scheduled for release yet, and being relatively cautious about the existing product pipeline, it has simultaneously lowered Net Profit forecasts under non-GAAP for NetEase in 2024 and 2025 by 2%, with expected figures of 33.4 billion and 37.2 billion yuan respectively.

Credit Suisse: Raises BeiGene's H-share target price from HKD 138.5 to HKD 139.7, reiterates "Buy" rating

The report indicates that BeiGene's sales in the first quarter of the 2024 fiscal year increased by 67.9% year-on-year, exceeding market expectations. The bank believes that sales of BeiGene's self-developed BTK inhibitors remain the main driving force behind its performance, with sales of related inhibitors increasing by 131.1% year-on-year.

According to the bank's statistics, the market share of the above inhibitors in the United States has increased to 24.1%, compared to 19.1% and 21.2% in the third and fourth quarters of last year, respectively. The bank also believes that the progress of the company's BCL-2 and BTK CDAC products this year is worth paying attention to